Chikujee Therapeutics is an innovative and dynamic company employing a unique approach to solving the most important and complex problems associated with targeted therapeutic delivery. By integrating the fields of organic and polymer chemistry, polymer physics, nanotechnology, biochemistry, and molecular biology, Chikujee is well-positioned to develop new polymeric biomaterials and drug carriers that will impact the millions of people worldwide who suffer from disease. In contrast to the use of off-the-shelf polymers to develop "new" delivery technologies, Chikujee  looks to design and biochemically tailor novel drug delivery vehicles to address key problems in drug delivery. This fundamentally different strategy has led to the development of new Biomolecular Oligomeric Silica hybrid (BOSH) molecules and the TSDV drug delivery platform, a versatile system that addresses the diverse requirements for advanced target specific drug delivery.